{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:45:05Z","timestamp":1791477905607,"version":"4.3.4"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Local funding"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS121826, NS099328, NS109209, NS122880, NS133979, and AG085401"],"award-info":[{"award-number":["NS121826, NS099328, NS109209, NS122880, NS133979, and AG085401"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM2302"],"award-info":[{"award-number":["01GM2302"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2022_EKSE.185"],"award-info":[{"award-number":["2022_EKSE.185"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson's","doi-asserted-by":"publisher","award":["ASAP-000282"],"award-info":[{"award-number":["ASAP-000282"]}],"id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["DHF\/R1\/201228"],"award-info":[{"award-number":["DHF\/R1\/201228"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002927","name":"Addenbrooke's Charitable Trust, Cambridge University Hospitals","doi-asserted-by":"publisher","award":["900325"],"award-info":[{"award-number":["900325"]}],"id":[{"id":"10.13039\/501100002927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000275","name":"Leverhulme Trust","doi-asserted-by":"publisher","award":["RPG-2022-257"],"award-info":[{"award-number":["RPG-2022-257"]}],"id":[{"id":"10.13039\/501100000275","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-022411"],"award-info":[{"award-number":["MJFF-022411"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["MJFF-023915"],"award-info":[{"award-number":["MJFF-023915"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2067\/1- 390729940"],"award-info":[{"award-number":["EXC 2067\/1- 390729940"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Parkinson\u2019s disease (PD) affects millions of people worldwide, but only 5\u201310% of patients suffer from a monogenic forms of the disease with Mendelian inheritance.\n                      <jats:italic>SNCA,<\/jats:italic>\n                      the gene encoding for the protein alpha-synuclein (aSyn), was the first to be associated with familial forms of PD and, since then, several missense variants and multiplications of the gene have been established as rare causes of autosomal dominant forms of PD. In this study, we report the identification of a novel\n                      <jats:italic>SNCA<\/jats:italic>\n                      mutation in a patient that presented with a complex neurogenerative disorder, and unconventional neuropathological findings. We also performed in depth molecular studies of the effects of the novel aSyn mutation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A patient carrying the novel aSyn missense mutation and the family members were studied. We present the clinical features, genetic testing\u2014whole exome sequencing (WES), and neuropathological findings. The functional consequences of this aSyn variant were extensively investigated using biochemical, biophysical, and cellular assays.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The patient exhibited a complex neurodegenerative disease that included generalized myocloni, bradykinesia, dystonia of the left arm and apraxia. WES identified a novel heterozygous\n                      <jats:italic>SNCA<\/jats:italic>\n                      variant (cDNA 40G\u2009&gt;\u2009A; protein G14R). Neuropathological examination showed extensive atypical aSyn pathology with frontotemporal lobar degeneration (FTLD)-type distribution and nigral degeneration pattern with abundant ring-like neuronal inclusions, and few oligodendroglial inclusions. Sanger sequencing confirmed the\n                      <jats:italic>SNCA<\/jats:italic>\n                      variant in one healthy, 86-year-old parent of the patient suggesting incomplete penetrance. NMR studies suggest that the G14R mutation induces a local structural alteration in aSyn, and lower thioflavin T binding in in vitro fibrillization assays. Interestingly, the G14R aSyn fibers display different fibrillar morphologies than Lewy bodies as revealed by cryo-electron microscopy. Cellular studies of the G14R variant revealed increased inclusion formation, enhanced membrane association, and impaired dynamic reversibility of serine\u2010129 phosphorylation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The atypical neuropathological features observed, which are reminiscent of those observed for the G51D aSyn variant, suggest a causal role of the\n                      <jats:italic>SNCA<\/jats:italic>\n                      variant with a distinct clinical and pathological phenotype, which is further supported by the properties of the mutant aSyn.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-025-00889-y","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:54:43Z","timestamp":1758876883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A novel alpha-synuclein G14R missense variant is associated with atypical neuropathological features"],"prefix":"10.1186","volume":"20","author":[{"given":"Christof","family":"Br\u00fccke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Azzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagendran","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ram\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita L.","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiamma","family":"Buratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Sicking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Gelpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswathy","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana R.","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio O.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janin","family":"Lautenschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zweckstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Fern\u00e1ndez-Busnadiego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zimprich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Fleming","family":"Outeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"889_CR1","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00401-023-02601-0","volume":"146","author":"M Flores-Leon","year":"2023","unstructured":"Flores-Leon M, Outeiro TF. More than meets the eye in Parkinson\u2019s disease and other synucleinopathies: from proteinopathy to lipidopathy. Acta Neuropathol. 2023;146:369\u201385.","journal-title":"Acta Neuropathol"},{"key":"889_CR2","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science. 1997;276:2045\u20137.","journal-title":"Science"},{"key":"889_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R. Goedert M \u03b1-synuclein in Lewy bodies. Nature. 1997;388:839\u201340.","journal-title":"Nature"},{"key":"889_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ana.410400513","volume":"40","author":"LI Golbe","year":"1996","unstructured":"Golbe LI, Di Iorio G, Sanges G, et al. Clinical genetic analysis of Parkinson\u2019s disease in the Contursi kindred. Ann Neurol. 1996;40:767\u201375.","journal-title":"Ann Neurol"},{"key":"889_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","volume":"28","author":"S Appel-Cresswell","year":"2013","unstructured":"Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, et al. Alpha-synuclein pH50Q, a novel pathogenic mutation for Parkinson\u2019s disease. Mov Disord. 2013;28:811\u20133.","journal-title":"Mov Disord"},{"key":"889_CR6","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-2317-6","volume":"585","author":"M Schweighauser","year":"2020","unstructured":"Schweighauser M, Shi Y, Tarutani A, et al. Structures of \u03b1-synuclein filaments from multiple system atrophy. Nature. 2020;585:464\u20139.","journal-title":"Nature"},{"key":"889_CR7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-05319-3","volume":"610","author":"Y Yang","year":"2022","unstructured":"Yang Y, Shi Y, Schweighauser M, et al. Structures of \u03b1-synuclein filaments from human brains with Lewy pathology. Nature. 2022;610:791\u20135.","journal-title":"Nature"},{"key":"889_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-023-06437-2","volume":"621","author":"SHW Scheres","year":"2023","unstructured":"Scheres SHW, Ryskeldi-Falcon B, Goedert M. Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids. Nature. 2023;621:701\u201310.","journal-title":"Nature"},{"key":"889_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/bs.pbr.2019.10.005","volume":"252","author":"IC Br\u00e1s","year":"2020","unstructured":"Br\u00e1s IC, Xylaki M. Outeiro TF Mechanisms of alpha-synuclein toxicity: An update and outlook. Prog Brain Res. 2020;252:91\u2013129.","journal-title":"Prog Brain Res"},{"key":"889_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01403-x","volume":"10","author":"DJ Koss","year":"2022","unstructured":"Koss DJ, Erskine D, Porter A, et al. Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies. Acta Neuropathol Commun. 2022;10:98.","journal-title":"Acta Neuropathol Commun"},{"key":"889_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/biology11040535","volume":"11","author":"K Ezzat","year":"2022","unstructured":"Ezzat K, Sturchio A, Espay AJ. Proteins do not replicate, they precipitate: phase transition and loss of function toxicity in amyloid pathologies. Biology. 2022;11:535.","journal-title":"Biology"},{"key":"889_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106077","volume":"122","author":"AJ Espay","year":"2024","unstructured":"Espay AJ, Lees AJ. Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson\u2019s disease. Parkinsonism Relat Disord. 2024;122:106077.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR13","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/mds.29162","volume":"37","author":"K Daida","year":"2022","unstructured":"Daida K, Shimonaka S, Shiba-Fukushima K, et al. \u0391-Synuclein V15A variant in familial Parkinson\u2019s disease exhibits a weaker lipid-binding property. Mov Disord. 2022;37:2075\u201385.","journal-title":"Mov Disord"},{"key":"889_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, et al. Ala30Pro mutation in the gene encoding \u03b1-synuclein in Parkinson\u2019s disease. Nat Genet. 1998;18:106\u20138.","journal-title":"Nat Genet"},{"key":"889_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage S, Anheim M, Letournel F, et al. G51d \u03b1-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann Neurol. 2013;73:459\u201371.","journal-title":"Ann Neurol"},{"key":"889_CR16","doi-asserted-by":"publisher","first-page":"248e7","DOI":"10.1016\/j.neurobiolaging.2017.05.022","volume":"57","author":"H Yoshino","year":"2017","unstructured":"Yoshino H, Hirano M, Stoessl AJ, et al. Homozygous alpha-synuclein pA53V in familial Parkinson\u2019s disease. Neurobiol Aging. 2017;57:248e7\u201312.","journal-title":"Neurobiol Aging"},{"key":"889_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","volume":"55","author":"JJ Zarranz","year":"2004","unstructured":"Zarranz JJ, Alegre J, G\u00f3mez-Esteban JC, et al. The new mutation, E46K, of \u03b1-synuclein causes Parkinson and Lewy body dementia. Ann Neurol. 2004;55:164\u201373.","journal-title":"Ann Neurol"},{"key":"889_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.parkreldis.2021.06.023","volume":"89","author":"C Fevga","year":"2021","unstructured":"Fevga C, Park Y, Lohmann E, et al. A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2021;89:63\u201372.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR19","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/mds.28534","volume":"36","author":"H Liu","year":"2021","unstructured":"Liu H, Koros C, Stroh\u00e4ker T, et al. A novel SNCA A30G mutation causes familial Parkinson\u02bcs disease. Mov Disord. 2021;36:1624\u201333.","journal-title":"Mov Disord"},{"key":"889_CR20","doi-asserted-by":"crossref","unstructured":"Pasanen P, Myllykangas L, Siitonen M, et al A novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson\u2019s disease-type pathology. Neurobiol Aging. 2014; 35: 2180e1\u20135","DOI":"10.1016\/j.neurobiolaging.2014.03.024"},{"key":"889_CR21","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1002\/mds.28735","volume":"36","author":"M Sokratous","year":"2021","unstructured":"Sokratous M, Breza M, Senkevich K, et al. \u0391-synuclein (SNCA) A30G mutation as a cause of a complex phenotype without parkinsonism. Mov Disord. 2021;36:2209\u201312.","journal-title":"Mov Disord"},{"key":"889_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00401-022-02403-w","volume":"143","author":"SAM Holec","year":"2022","unstructured":"Holec SAM, Liu SL. Woerman al consequences of variability in \u03b1-synuclein fibril structure on strain biology. Acta Neuropathol. 2022;143:311\u201330.","journal-title":"Acta Neuropathol"},{"key":"889_CR23","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1002\/mds.28742","volume":"36","author":"H Liu","year":"2021","unstructured":"Liu H, Koros C, Stefanis L, Gasser T. Reply to: \u201c\u03b1-Synuclein (SNCA) A30G Mutation as a Cause of a Complex Phenotype Without Parkinsonism.\u201d Mov Disord. 2021;36:2212\u20133.","journal-title":"Mov Disord"},{"key":"889_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, et al. \u0391-synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4:160\u20134.","journal-title":"Nat Cell Biol"},{"key":"889_CR25","doi-asserted-by":"crossref","unstructured":"Ramalingam N, Jin S-X, Moors TE, et al Dynamic physiological \u03b1-synuclein S129 phosphorylation is driven by neuronal activity. NPJ Parkinsons Dis. 2023; 9: 4","DOI":"10.1038\/s41531-023-00444-w"},{"key":"889_CR26","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1021\/bi010616g","volume":"40","author":"J Li","year":"2001","unstructured":"Li J, Uversky VN. Fink al effect of familial Parkinson\u2019s disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human \u03b1-synuclein. Biochemistry. 2001;40:11604\u201313.","journal-title":"Biochemistry"},{"key":"889_CR27","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","volume":"23","author":"MB Fares","year":"2014","unstructured":"Fares MB, Ait-Bouziad N, Dikiy I, et al. The novel Parkinson\u2019s disease linked mutation G51D attenuates in vitro aggregation and membrane binding of \u03b1-synuclein, and enhances its secretion and nuclear localization in cells. Hum Mol Genet. 2014;23:4491\u2013509.","journal-title":"Hum Mol Genet"},{"key":"889_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-016-0402-8","volume":"4","author":"DF L\u00e1zaro","year":"2016","unstructured":"L\u00e1zaro DF, Dias MC, Carija A, et al. The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation. Acta Neuropathol Commun. 2016;4:128.","journal-title":"Acta Neuropathol Commun"},{"key":"889_CR29","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/mds.28488","volume":"36","author":"JJ Kim","year":"2021","unstructured":"Kim JJ, Makarious MB, Bandres-Ciga S, et al. The Parkinson\u2019s Disease DNA variant browser. Mov Disord. 2021;36:1250\u20138.","journal-title":"Mov Disord"},{"key":"889_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310\u20135.","journal-title":"Nat Genet"},{"key":"889_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248\u20139.","journal-title":"Nat Methods"},{"key":"889_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41586-021-04043-8","volume":"599","author":"J Frazer","year":"2021","unstructured":"Frazer J, Notin P, Dias M, et al. Disease variant prediction with deep generative models of evolutionary data. Nature. 2021;599:91\u20135.","journal-title":"Nature"},{"key":"889_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng J, Novati G, Pan J, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science. 2023;381:eadg7492.","journal-title":"Science"},{"key":"889_CR34","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/biom12020324","volume":"12","author":"M Al-Azzani","year":"2022","unstructured":"Al-Azzani M, K\u00f6nig A. Outeiro tf production of recombinant alpha-synuclein: still no standardized protocol in sight. Biomolecules. 2022;12:324.","journal-title":"Biomolecules"},{"key":"889_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0009-2614(80)80041-8","volume":"69","author":"G Bodenhausen","year":"1980","unstructured":"Bodenhausen G, Ruben DJ. Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy. Chem Phys Lett. 1980;69:185\u20139.","journal-title":"Chem Phys Lett"},{"key":"889_CR36","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s12035-021-02713-2","volume":"59","author":"E Vasili","year":"2022","unstructured":"Vasili E, Dominguez-Meijide A, Flores-Le\u00f3n M, et al. Endogenous levels of alpha-synuclein modulate seeding and aggregation in cultured cells. Mol Neurobiol. 2022;59:1273\u201384.","journal-title":"Mol Neurobiol"},{"key":"889_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng SQ, Palovcak E, Armache JP, Verba KA, Cheng Y. Agard DA motioncor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods. 2017;14:331\u20132.","journal-title":"Nat Methods"},{"key":"889_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J Struct Biol. 2015;192:216\u201321.","journal-title":"J Struct Biol"},{"key":"889_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-019-0437-z","volume":"2","author":"T Wagner","year":"2019","unstructured":"Wagner T, Merino F, Stabrin M, et al. SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun Biol. 2019;2:218.","journal-title":"Commun Biol"},{"key":"889_CR40","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1042\/BCJ20210708","volume":"478","author":"D Kimanius","year":"2021","unstructured":"Kimanius D, Dong L, Sharov G, Nakane T. Scheres SHW New tools for automated cryo-EM single-particle analysis in RELION-40. Biochemical Journal. 2021;478:4169\u201385.","journal-title":"Biochemical Journal"},{"key":"889_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley P, Lohkamp B, Scott WG. Cowtan k features and development of coot. Acta Crystallogr D Biol Crystallogr. 2010;66:486\u2013501.","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"889_CR42","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1107\/S2059798319011471","volume":"75","author":"D Liebschner","year":"2019","unstructured":"Liebschner D, Afonine PV, Baker ML, et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol. 2019;75:861\u201377.","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"889_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004741","volume":"10","author":"DF L\u00e1zaro","year":"2014","unstructured":"L\u00e1zaro DF, Rodrigues EF, Langohr R, et al. Systematic comparison of the effects of Alpha-synuclein mutations on its oligomerization and aggregation. PLoS Genet. 2014;10:e1004741.","journal-title":"PLoS Genet"},{"key":"889_CR44","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202357145","volume":"24","author":"N Ramalingam","year":"2023","unstructured":"Ramalingam N, Brontesi L, Jin S, Selkoe DJ, Dettmer U. Dynamic reversibility of \u03b1-synuclein serine-129 phosphorylation is impaired in synucleinopathy models. EMBO Rep. 2023;24:e57145.","journal-title":"EMBO Rep"},{"key":"889_CR45","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"},{"key":"889_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20462-z","volume":"12","author":"D Park","year":"2021","unstructured":"Park D, Wu Y, Lee SE, et al. Cooperative function of synaptophysin and synapsin in the generation of synaptic vesicle-like clusters in non-neuronal cells. Nat Commun. 2021;12:263.","journal-title":"Nat Commun"},{"key":"889_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41467-023-36081-3","volume":"14","author":"D Park","year":"2023","unstructured":"Park D, Wu Y, Wang X, Gowrishankar S, Baublis A. De Camilli P synaptic vesicle proteins and ATG9A self-organize in distinct vesicle phases within synapsin condensates. Nat Commun. 2023;14:455.","journal-title":"Nat Commun"},{"key":"889_CR48","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.molcel.2018.12.007","volume":"73","author":"X Wu","year":"2019","unstructured":"Wu X, Cai Q, Shen Z, et al. RIM and RIM-BP Form Presynaptic Active-Zone-like Condensates via Phase Separation. Mol Cell. 2019;73:971\u201384.","journal-title":"Mol Cell"},{"key":"889_CR49","doi-asserted-by":"publisher","first-page":"W301","DOI":"10.1093\/nar\/gku399","volume":"42","author":"I Walsh","year":"2014","unstructured":"Walsh I, Seno F, Tosatto SCE, Trovato A. PASTA 20: an improved server for protein aggregation prediction. Nucleic Acids Res. 2014;42:W301-7.","journal-title":"Nucleic Acids Res"},{"key":"889_CR50","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jmb.2004.06.088","volume":"342","author":"R Linding","year":"2004","unstructured":"Linding R, Schymkowitz J, Rousseau F, Diella F, Serrano L. A comparative study of the relationship between protein structure and \u03b2-aggregation in globular and intrinsically disordered proteins. J Mol Biol. 2004;342:345\u201353.","journal-title":"J Mol Biol"},{"key":"889_CR51","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/nbt1012","volume":"22","author":"AM Fernandez-Escamilla","year":"2004","unstructured":"Fernandez-Escamilla AM, Rousseau F, Schymkowitz J. Serrano l prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol. 2004;22:1302\u20136.","journal-title":"Nat Biotechnol"},{"key":"889_CR52","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48907","volume":"8","author":"R Guerrero-Ferreira","year":"2019","unstructured":"Guerrero-Ferreira R, Taylor NMI, Arteni AA, et al. Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy. Elife. 2019;8:e48907.","journal-title":"Elife"},{"key":"889_CR53","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.93562","author":"L Frey","year":"2024","unstructured":"Frey L, Ghosh D, Qureshi BM, et al. On the pH-dependence of \u03b1-synuclein amyloid polymorphism and the role of secondary nucleation in seed-based amyloid propagation. Elife. 2024. https:\/\/doi.org\/10.7554\/eLife.93562.","journal-title":"Elife"},{"key":"889_CR54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle MD, Comellas G, Nieuwkoop AJ, et al. Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein. Nat Struct Mol Biol. 2016;23:409\u201315.","journal-title":"Nat Struct Mol Biol"},{"key":"889_CR55","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/2211-5463.13110","volume":"11","author":"S L\u00f6vestam","year":"2021","unstructured":"L\u00f6vestam S, Schweighauser M, Matsubara T, et al. Seeded assembly in vitro does not replicate the structures of \u03b1-synuclein filaments from multiple system atrophy. FEBS Open Bio. 2021;11:999\u20131013.","journal-title":"FEBS Open Bio"},{"key":"889_CR56","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00401-023-02550-8","volume":"145","author":"Y Yang","year":"2023","unstructured":"Yang Y, Garringer HJ, Shi Y, et al. New SNCA mutation and structures of \u03b1-synuclein filaments from juvenile-onset synucleinopathy. Acta Neuropathol. 2023;145:561\u201372.","journal-title":"Acta Neuropathol"},{"key":"889_CR57","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/s41556-024-01451-6","volume":"26","author":"A Agarwal","year":"2024","unstructured":"Agarwal A, Chandran A, Raza F, et al. VAMP2 regulates phase separation of \u03b1-synuclein. Nat Cell Biol. 2024;26:1296\u2013308.","journal-title":"Nat Cell Biol"},{"key":"889_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.166961","volume":"433","author":"C Hoffmann","year":"2021","unstructured":"Hoffmann C, Sansevrino R, Morabito G, et al. Synapsin condensates recruit alpha-synuclein. J Mol Biol. 2021;433:166961.","journal-title":"J Mol Biol"},{"key":"889_CR59","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06807","volume":"4","author":"S Kroschwald","year":"2015","unstructured":"Kroschwald S, Maharana S, Mateju D, et al. Promiscuous interactions and protein disaggregases determine the material state of stress-inducible RNP granules. Elife. 2015;4:e06807.","journal-title":"Elife"},{"key":"889_CR60","volume":"3","author":"S Kroschwald","year":"2017","unstructured":"Kroschwald S, Maharana S, Simon A. Hexanediol: a chemical probe to investigate the material properties of membrane-less compartments. Matters. 2017;3:e201702000010.","journal-title":"Matters"},{"key":"889_CR61","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2016.10.003","volume":"167","author":"Y Lin","year":"2016","unstructured":"Lin Y, Mori E, Kato M, et al. Toxic PR Poly-Dipeptides Encoded by the C9orf72 Repeat Expansion Target LC Domain Polymers. Cell. 2016;167:789-802e2.","journal-title":"Cell."},{"key":"889_CR62","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1083\/jcb.201010104","volume":"192","author":"DL Updike","year":"2011","unstructured":"Updike DL, Hachey SJ, Kreher J, Strome S. P granules extend the nuclear pore complex environment in the C elegans germ line. J Cell Biol. 2011;192:939\u201348.","journal-title":"J Cell Biol"},{"key":"889_CR63","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.1090439","volume":"302","author":"TF Outeiro","year":"2003","unstructured":"Outeiro TF, Lindquist S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science. 2003;302:1772\u20135.","journal-title":"Science"},{"key":"889_CR64","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","volume":"68","author":"J Fuchs","year":"2007","unstructured":"Fuchs J, Nilsson C, Kachergus J, et al. Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology. 2007;68:916\u201322.","journal-title":"Neurology"},{"key":"889_CR65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.parkreldis.2009.06.007","volume":"15","author":"A Puschmann","year":"2009","unstructured":"Puschmann A, Ross OA, Vilari\u00f1o-G\u00fcell C, et al. A Swedish family with de novo \u03b1-synuclein A53T mutation: evidence for early cortical dysfunction. Parkinsonism Relat Disord. 2009;15:627\u201332.","journal-title":"Parkinsonism Relat Disord"},{"key":"889_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/ana.67","volume":"49","author":"PJ Spira","year":"2001","unstructured":"Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr \u03b1-synuclein mutation. Ann Neurol. 2001;49:313\u20139.","journal-title":"Ann Neurol"},{"key":"889_CR67","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, De Vos RAI, Jansen Steur ENH. Braak E Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"889_CR68","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1002\/mds.20537","volume":"20","author":"KA Jellinger","year":"2005","unstructured":"Jellinger KA, Seppi K, Wenning GK. Grading of neuropathology in multiple system atrophy: proposal for a novel scale. Mov Disord. 2005;20:S29-36.","journal-title":"Mov Disord"},{"key":"889_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. 2017;3:17013.","journal-title":"Nat Rev Dis Primers"},{"key":"889_CR70","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00401-013-1096-7","volume":"125","author":"AP Kiely","year":"2013","unstructured":"Kiely AP, Asi YT, Kara E, et al. A-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson\u2019s disease and multiple system atrophy? Acta Neuropathol. 2013;125:753\u201369.","journal-title":"Acta Neuropathol"},{"key":"889_CR71","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga S, Sekiya H, Kondru N, Ross OA. Dickson DW neuropathology and molecular diagnosis of synucleinopathies. Mol Neurodegener. 2021;16:83.","journal-title":"Mol Neurodegener"},{"key":"889_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-015-0038-3","volume":"10","author":"AP Kiely","year":"2015","unstructured":"Kiely AP, Ling H, Asi YT, et al. Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation. Mol Neurodegener. 2015;10:41.","journal-title":"Mol Neurodegener"},{"key":"889_CR73","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","volume":"122","author":"KA Josephs","year":"2011","unstructured":"Josephs KA, Hodges JR, Snowden JS, et al. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122:137\u201353.","journal-title":"Acta Neuropathol"},{"key":"889_CR74","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jamaneurol.2022.5128","volume":"80","author":"G Logroscino","year":"2023","unstructured":"Logroscino G, Piccininni M, Graff C, et al. Incidence of syndromes associated with frontotemporal lobar degeneration in 9 European countries. JAMA Neurol. 2023;80:279\u201386.","journal-title":"JAMA Neurol"},{"key":"889_CR75","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-007-0236-3","volume":"114","author":"J Snowden","year":"2007","unstructured":"Snowden J, Neary D. Mann frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 2007;114:31\u20138.","journal-title":"Acta Neuropathol"},{"key":"889_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IRA MacKenzie","year":"2010","unstructured":"MacKenzie IRA, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119:1\u20134.","journal-title":"Acta Neuropathol"},{"key":"889_CR77","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00401-015-1442-z","volume":"130","author":"N Aoki","year":"2015","unstructured":"Aoki N, Boyer PJ, Lund C, et al. Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with \u03b1-synuclein. Acta Neuropathol. 2015;130:93\u2013105.","journal-title":"Acta Neuropathol"},{"key":"889_CR78","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/neup.12687","volume":"40","author":"A Kapasi","year":"2020","unstructured":"Kapasi A, Brosch JR, Nudelman KN, Agrawal S, Foroud TM. Schneider JA a novel SNCA E83Q mutation in a case of dementia with Lewy bodies and atypical frontotemporal lobar degeneration. Neuropathology. 2020;40:620\u20136.","journal-title":"Neuropathology"},{"key":"889_CR79","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","volume":"307","author":"D Eliezer","year":"2001","unstructured":"Eliezer D, Kutluay E, Bussell R, Browne G. Conformational properties of \u03b1-synuclein in its free and lipid-associated states. J Mol Biol. 2001;307:1061\u201373.","journal-title":"J Mol Biol"},{"key":"889_CR80","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/1873-3468.13047","volume":"592","author":"M Rovere","year":"2018","unstructured":"Rovere M, Sanderson JB, Fonseca-Ornelas L, Patel DS, Bartels T. Refolding of helical soluble \u03b1-synuclein through transient interaction with lipid interfaces. FEBS Lett. 2018;592:1464\u201372.","journal-title":"FEBS Lett"},{"key":"889_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00623","volume":"12","author":"U Dettmer","year":"2018","unstructured":"Dettmer U. Rationally designed variants of \u03b1-synuclein illuminate its in vivo structural properties in health and disease. Front Neurosci. 2018;12:623.","journal-title":"Front Neurosci"},{"key":"889_CR82","doi-asserted-by":"publisher","first-page":"34393","DOI":"10.1074\/jbc.M004851200","volume":"275","author":"RJ Perrin","year":"2000","unstructured":"Perrin RJ, Woods WS, Clayton DF. George jm interaction of human \u03b1-synuclein and Parkinson\u2019s disease variants with phospholipids: structural analysis using site-directed mutagenesis. J Biol Chem. 2000;275:34393\u20138.","journal-title":"J Biol Chem"},{"key":"889_CR83","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jmb.2014.09.026","volume":"427","author":"P Sormanni","year":"2015","unstructured":"Sormanni P, Aprile FA, Vendruscolo M. The camsol method of rational design of protein mutants with enhanced solubility. J Mol Biol. 2015;427:478\u201390.","journal-title":"J Mol Biol"},{"key":"889_CR84","doi-asserted-by":"publisher","first-page":"12961","DOI":"10.1038\/s41598-017-13210-9","volume":"7","author":"M Burdukiewicz","year":"2017","unstructured":"Burdukiewicz M, Sobczyk P, R\u00f6diger S, Duda-Madej A, MacKiewicz P. Kotulska m amyloidogenic motifs revealed by n-gram analysis. Sci Rep. 2017;7:12961.","journal-title":"Sci Rep"},{"key":"889_CR85","doi-asserted-by":"publisher","first-page":"W300","DOI":"10.1093\/nar\/gkz321","volume":"4","author":"A Kuriata","year":"2019","unstructured":"Kuriata A, Iglesias V, Pujols J, Kurcinski M, Kmiecik S. Ventura S Aggrescan3D (A3D) 20: Prediction and engineering of protein solubility. Nucleic Acids Res. 2019;4:W300\u20137.","journal-title":"Nucleic Acids Res"},{"key":"889_CR86","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1038\/srep03525","volume":"3","author":"S Sharma","year":"2013","unstructured":"Sharma S, Sarkar S, Paul SS, Roy S. Chattopadhyay k a small molecule chemical chaperone optimizes its unfolded state contraction and denaturant like properties. Sci Rep. 2013;3:3525.","journal-title":"Sci Rep"},{"key":"889_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.759729","volume":"14","author":"SSA Mamsa","year":"2021","unstructured":"Mamsa SSA, Meloni BP. Arginine and arginine-rich peptides as modulators of protein aggregation and cytotoxicity associated with Alzheimer\u2019s disease. Front Mol Neurosci. 2021;14:759729.","journal-title":"Front Mol Neurosci"},{"key":"889_CR88","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner B, Jappelli R, Maji SK, et al. In vivo demonstration that \u03b1-synuclein oligomers are toxic. Proc Natl Acad Sci U S A. 2011;108:4194\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"889_CR89","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, et al. Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature. 2020;578:273\u20137.","journal-title":"Nature"},{"key":"889_CR90","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1016\/j.neuron.2023.11.020","volume":"111","author":"LA Parra-Rivas","year":"2023","unstructured":"Parra-Rivas LA, Madhivanan K, Aulston BD, et al. Serine-129 phosphorylation of \u03b1-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. Neuron. 2023;111:4006\u201323.","journal-title":"Neuron"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00889-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00889-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00889-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:02:58Z","timestamp":1763467378000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00889-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00889-y","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"3 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\"The original article has been updated to amend co-author, Rub\u00e9n Fern\u00e1ndez-Busnadiego's name.\"","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received the approval of the ethics committee of the Medical University of Vienna (EK1844\/2019), and written informed consent was obtained from all subjects involved to participate in the genetic research described in this study. All animal procedures were conducted in accordance with the approval from the Institutional Animal Care and Use Committee at BWH, under protocol number 2016N000305.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read and approved the manuscript submitted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}